StimLabs Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • StimLabs's estimated annual revenue is currently $63.5M per year.(i)
  • StimLabs's estimated revenue per employee is $251,000

Employee Data

  • StimLabs has 253 Employees.(i)
  • StimLabs grew their employee count by 3% last year.

StimLabs's People

NameTitleEmail/Phone
1
Area VP - EastReveal Email/Phone
2
West Area VPReveal Email/Phone
3
CEOReveal Email/Phone
4
VP Product DevelopmentReveal Email/Phone
5
VP Quality Assurance & Regulatory AffairsReveal Email/Phone
6
VP Information TechnologyReveal Email/Phone
7
VP Market AccessReveal Email/Phone
8
Compliance OfficerReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Director, R&D BiologicsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M29N/AN/AN/A
#2
$104.7M4173%N/AN/A
#3
$6M24-23%N/AN/A
#4
$5M400%$16MN/A
#5
$6M24-23%N/AN/A
#6
$10.8M435%N/AN/A
#7
$3M240%$50MN/A
#8
$10M40-13%N/AN/A
#9
$5M2011%N/AN/A
#10
$17.6M703%N/AN/A
Add Company

What Is StimLabs?

StimLabs was founded in 2015 with a desire to advance the state of regenerative medicine. In pursuit of this goal, StimLabs has gathered exceptional scientific and clinical minds to develop and commercialize new bioactive technologies. Within a year of its inception, StimLabs conceptualized and launched a suite of amniotic-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property.

keywords:N/A

N/A

Total Funding

253

Number of Employees

$63.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

StimLabs News

2022-04-17 - Global Amniotic Products Market 2022 Key Factors – MiMedx ...

... StimLabs; VIVEX Biologics; LifeCell International; NuVision Biotherapies; Genesis Biologics. The global Amniotic Products market research discusses the...

2022-03-22 - StimLabs, LLC. Announces Addition of New Product, Vialize ...

The decision to rebrand their leading lyophilized dCHPM allograft is an integral part of StimLabs' recent strategic branding initiative to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$51.9M258-5%N/A
#2
$73.3M2727%N/A
#3
$92.2M2897%N/A
#4
$127.9M31010%N/A
#5
$58.2M3211%N/A